Research output per year
Research output per year
Fingerprint
Dive into the research topics where Jorge Eduardo Cortes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
THERAPY OF CML
Cortes, J. E., Kurzrock, R., Ming-Sheng, L., Reading, C., Emerson, S., Liang, J., Deisseroth, A., Feinberg, A., Siciliano, M., Kantarjian, H., Talpaz, M., Andreeff, M., Kornblau, S., Thall, P., Issa, J. P., Estrov, Z., Arlinghaus, R. B., Deininger, M., Champlin, R., Shpall, E., Austin, D., Claxton, D., Belmont, J., Reisner, Y. & Issa, K.
Project: Research project
Research output
-
Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations
Shoukier, M., Kadia, T., Konopleva, M., Alotaibi, A. S., Alfayez, M., Loghavi, S., Patel, K. P., Kanagal-Shamanna, R., Cortes, J., Samra, B., Jabbour, E., Garcia-Manero, G., Takahashi, K., Pierce, S., Short, N. J., Yilmaz, M., Sasaki, K., Masarova, L., Pemmaraju, N., Borthakur, G. & 4 others, , Feb 1 2021, In: Cancer. 127, 3, p. 381-390 10 p.Research output: Contribution to journal › Article › peer-review
-
Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Kang, D., Ludwig, E., Jaworowicz, D., Huang, H., Fiedler-Kelly, J., Cortes, J., Ganguly, S., Khaled, S., Krämer, A., Levis, M., Martinelli, G., Perl, A., Russell, N., Abutarif, M., Choi, Y. & Yin, O., 2021, (Accepted/In press) In: Cancer Chemotherapy and Pharmacology.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia
Cortes, J., Podoltsev, N., Kantarjian, H., Borthakur, G., Zeidan, A. M., Stahl, M., Taube, T., Fagan, N., Rajeswari, S. & Uy, G. L., Jan 2021, In: International Journal of Hematology. 113, 1, p. 92-99 8 p.Research output: Contribution to journal › Article › peer-review
-
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study
Montesinos, P., Roboz, G. J., Bulabois, C. E., Subklewe, M., Platzbecker, U., Ofran, Y., Papayannidis, C., Wierzbowska, A., Shin, H. J., Doronin, V., Deneberg, S., Yeh, S. P., Ozcan, M. A., Knapper, S., Cortes, J., Pollyea, D. A., Ossenkoppele, G., Giralt, S., Döhner, H., Heuser, M. & 5 others, , Jan 2021, In: Leukemia. 35, 1, p. 62-74 13 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia–a distinct subtype with favorable prognosis
Yilmaz, M., Kantarjian, H. M., Toruner, G., Yin, C. C., Kanagal-Shamanna, R., Cortes, J. E., Issa, G., Short, N. J., Khoury, J. D., Garcia-Manero, G., Ravandi, F., Kadia, T., Konopleva, M., Wierda, W. G., Jain, N., Estrov, Z., Sasaki, K., Pierce, S., O'Brien, S. M. & Jabbour, E. J., 2021, In: Leukemia and Lymphoma. 62, 1, p. 224-228 5 p.Research output: Contribution to journal › Article › peer-review